We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Should You Buy Neil Woodford’s China-Proof Shares Imperial Tobacco Group PLC, AstraZeneca plc And BT Group plc?

Neil Woodford’s top holdings Imperial Tobacco Group PLC (LON:IMT), AstraZeneca plc (LON:AZN) and BT Group plc (LON:BT.A) are an antidote to his concerns about China.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Renowned fund manager Neil Woodford has been concerned for some time about the Chinese economy, and what it means for the global economy as a whole. He discusses the subject in some detail in a blog post today.

Woodford suggests that recent growth figures coming out of China have lacked credibility when compared with other real economic data, noting:

Should you buy AstraZeneca Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

“Even the Chinese Premier, Li Keqiang, allegedly mistrusts the country’s official economic statistics, preferring to track growth by looking at real data. The Li Keqiang Index, as it has become known, tracks growth in outstanding bank loans, electricity production and rail freight volumes, and currently shows a reading of just 2.5% year-on-year. It last visited that level in November 2008, just after Lehman collapsed”.

Woodford suggests that the number of reasons to be cautious about China is increasing. He particularly highlights what will be an inevitably long and bumpy transition from heavy infrastructure investment to a more Western consumption-based economy. Furthermore, he reckons the State is struggling to adopt the required political approach for such a transition, as demonstrated by recent interventions in the stock and currency markets.

The level of private sector debt in the Chinese economy is another big concern Woodford highlights. He says the level is “alarming” and suggests that the Chinese economy will have to go through “a period of prolonged debt moderation”. He also notes that China has scope to lower interest rates, which could export deflation to the rest of the world, with “signification ramifications for the global economic outlook”.

Woodford-watchers will know he has been concerned about the risks emanating from China for some years, and has built his portfolios in the expectation that there’ll be little help from macroeconomic tailwinds. As such, he has populated his portfolios with companies that are more in control of their own destinies — avoiding, oil companies, miners and banks.

The top holding in Woodford’s equity income fund, Imperial Tobacco (LSE: IMT), is a prime example of a company more in control of its own destiny. Tobacco consumption is not really dependent on buoyant economies. The industry does face some headwinds, caused by increased health awareness in developed countries, but Woodford reckons the prospects and cash-generative qualities of tobacco companies continue to be under-appreciated by the market. Imperial trades on a forward P/E of 15 and offers a prospective 4.4% dividend yield, which looks attractive for such a “defensive” company.

Woodford’s no. two holding AstraZeneca (LSE: AZN) may be at the other end of the health spectrum to Imperial, but it also has solid defensive qualities. In addition, the big pharma company should benefit from demographic trends of ageing populations. Woodford believes Astra did the right thing in rejecting a £55 a share takeover bid by US giant Pfizer last year. With the shares now trading at under £42 (forward P/E 16, yield 4.2%) you have an idea of how much value Woodford sees in the company.

BT (LSE: BT-A) is another of Woodford’s top five holdings. Increasingly, packages of fixed line, mobile, broadband and pay-TV are becoming more of a staple for consumers than a luxury. BT’s agreed acquisition of mobile group EE will extend the group’s capabilities, and, after some initial concerns, Woodford decided that the acquisition was a good move for BT and its shareholders. If he’s right, BT’s current forward P/E of 13 and yield of 3.5% represent excellent value.

G A Chester has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

At 8.1%, are investors missing the bigger story behind Legal & General shares?

Andrew Mackie explores Legal & General shares and asks whether investors are still viewing it too narrowly as a yield…

Read more »

Young black female footballer training on stadium pitch
Investing Articles

How has this FTSE 250 share surged ANOTHER 7% today?

Applied Nutrition shares have soared on Monday after another brilliant trading update. So what's the FTSE 250 company's secret?

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

The stock market game you’re actually playing (and why you might be losing)

Our writer recounts a painful experience of making a rash stock market decision based on emotions, not logic – and…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Why is EasyJet stock suddenly a takeover target for US investors?

Andrew Mackie looks at easyjet shares jumping on US takeover talk — but is this a genuine re-rating or just…

Read more »

Young Black woman looking concerned while in front of her laptop
Investing Articles

Have investors got BT shares all wrong?

BT shares spiked during the 1990s telecom boom, then struggled for two decades. Harvey Jones says it's the future that…

Read more »

BUY AND HOLD spelled in letters on top of a pile of books. Alongside is a piggy bank in glasses. Buy and hold is a popular long term stock and shares strategy.
Investing Articles

Looking for buying opportunities in June? Here’s 1 to consider from my Stocks and Shares ISA

The conflict in Iran is making one of the investments in Stephen Wright’s Stocks and Shares ISA volatile. But could…

Read more »

Row of blue European Union flags in Brussels.
Investing Articles

After crashing 13.7% today, is Wise now a stock market bargain at 805p?

Wise was one of the biggest fallers on the UK stock market today. What on earth is going on with…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

At 8% is this eye-popping FTSE 100 dividend yield simply too good to be true?

The dividend yield is to die for, but the share price is lacking in life. Harvey Jones examines whether this…

Read more »